Incremental Value of the CRUSADE, ACUITY, and HAS‐BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy

Incremental Value of the CRUSADE, ACUITY, and HAS‐BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy

Background Multiple scores have been proposed to stratify bleeding risk, but their value to guide dual antiplatelet therapy duration has never been appraised. We compared the performance of the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Im...

Full description

Bibliographic Details
Main Authors: Francesco Costa, Jan G. Tijssen, Sara Ariotti, Sara Giatti, Elisabetta Moscarella, Paolo Guastaroba, Rossana De Palma, Giuseppe Andò, Giuseppe Oreto, Felix Zijlstra, Marco Valgimigli
Format: Article
Language:English
Published: Wiley 2015-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
ACUITY
bleeding risk score
clopidogrel
CRUSADE
duration of dual antiplatelet therapy
HAS‐BLED
Online Access:https://doi.org/10.1161/JAHA.115.002524

Internet

https://doi.org/10.1161/JAHA.115.002524

Similar Items